ANALEPTICS

[21] BOOKER WM, 1950, J PHARMACOL EXP THER, V98, P207

[22] BORODKIN YS, 1972, FARMAKOL TOKSIKOL, V35, P533

[23] BORYS HK, 1969, INT J NEUROPHARMACOL, V8, P627

[24] BOYLE JF, 1962, P S TREATMENT RESPIR, P191

[25] BRAND L, 1962, B NEW YORK ACAD MED, V38, P702

[26] HEPATIC LIPID ALTERATIONS PRODUCED BY DOXAPRAM [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1966, 9 (02) : 347 - &

[27] LONG-TERM AND SHORT-TERM EFFECTS OF ORAL PRETHCAMIDE IN CHRONIC VENTILATORY FAILURE [J]. BMJ-BRITISH MEDICAL JOURNAL, 1970, 2 (5712): : 764 - +

[28] BROGHAMMER H, 1967, ARZNEI-FORSCHUNG, V17, P220

[29] BROUN GR, 1972, B EXP BIOL MED+, V73, P70

[30] BRUCE DW, 1964, LANCET, V1, P1010

[21] BOOKER WM, 1950, J PHARMACOL EXP THER, V98, P207

[22] BORODKIN YS, 1972, FARMAKOL TOKSIKOL, V35, P533

[23] BORYS HK, 1969, INT J NEUROPHARMACOL, V8, P627

[24] BOYLE JF, 1962, P S TREATMENT RESPIR, P191

[25] BRAND L, 1962, B NEW YORK ACAD MED, V38, P702

[26] HEPATIC LIPID ALTERATIONS PRODUCED BY DOXAPRAM [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1966, 9 (02) : 347 - &

[27] LONG-TERM AND SHORT-TERM EFFECTS OF ORAL PRETHCAMIDE IN CHRONIC VENTILATORY FAILURE [J]. BMJ-BRITISH MEDICAL JOURNAL, 1970, 2 (5712): : 764 - +

[28] BROGHAMMER H, 1967, ARZNEI-FORSCHUNG, V17, P220

[29] BROUN GR, 1972, B EXP BIOL MED+, V73, P70

[30] BRUCE DW, 1964, LANCET, V1, P1010